Related Experiment Videos

Insights

This study evaluated antifungal drugs for treating Coccidioides immitis brain infections in mice. Amphotericin B showed the highest efficacy, while fluconazole and ketoconazole also prolonged survival.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Coccidioides immitis causes fungal infections, including potentially fatal meningitis.
  • Effective treatment options for severe coccidioidal infections, particularly neurococcidioidomycosis, are crucial.

Purpose of the Study:

  • To compare the efficacy of fluconazole, amphotericin B, and ketoconazole in a murine model of Coccidioides immitis brain infection.
  • To assess the impact of these antifungal agents on survival rates and fungal burden in the brain.

Main Methods:

  • Male ICR mice were intracerebrally inoculated with Coccidioides immitis endospores.
  • Mice were subsequently treated with water (control), fluconazole, amphotericin B (Fungizone), or ketoconazole (Nizoral).
  • Survival times and brain C. immitis colony counts were measured.

Main Results:

  • All tested antifungal drugs (fluconazole, amphotericin B, ketoconazole) significantly prolonged survival compared to the control group.
  • These drugs also led to a reduction in C. immitis colony counts within the brain.
  • Amphotericin B demonstrated superior efficacy compared to fluconazole.
  • High-dose oral fluconazole resulted in longer survival than ketoconazole.

Conclusions:

  • Fluconazole, amphotericin B, and ketoconazole show promise in treating experimental Coccidioides immitis brain infections.
  • Amphotericin B is more effective than fluconazole in this model.
  • Further research is warranted to establish the clinical utility of fluconazole for coccidioidal meningitis.

Related Concept Videos